InBody Co., Ltd.: The Story Behind the 96% Surge in Operating Profit… Excluding Exchange Rate Effects, Profit Declined Compared to the Previous Quarter
[Edaily Reporter KIM SAE-MI ] InBody Co., Ltd.(041830)reported that its operating profit for the third quarter of this year nearly doubled year-over-year; however, its recurring operating profit—excluding one-time accounting effects resulting from exchange rate fluctuations—decreased compared to the previous quarter. While operating profit increased due to the strengthening won, net income was cut in half due to valuation losses caused by exchange rate fluctuations.
InBody Co., Ltd. headquarters in Gangnam-gu, Seoul (Photo:KIM SAE-MI )According to the Financial Supervisory Service’s electronic disclosure system on the 20th, InBody Co., Ltd.’s operating profit for the third quarter of this year, based on consolidated financial statements, was 19.3 billion won, a 96.5% increase compared to the same period last year. During the same period, revenue rose 19.2% to 71.3 billion won, while net income fell 54.9% to 4.2 billion won. This figure is 200 million won lower than the preliminary net income of 4.4 billion won announced on the 5th.
Revenue Up 19% While Cost of Goods Sold Falls 37%… Exchange Rate Effect
Behind the sharp rise in operating profit lies an unusual decrease in the cost of goods sold. InBody Co., Ltd.’s consolidated cost of goods sold for the third quarter fell 36.9% from 15.1 billion won last year to 9.6 billion won this year. In other words, while revenue increased by 11.5 billion won, the cost of goods sold actually decreased by approximately 5.6 billion won. Consequently, the gross profit margin surged by 11.9 percentage points (p), rising from 74.7% to 86.6%. In contrast, the standalone gross profit margin fell from 65.2% to 62.0% over the same period.
KIWOOM Securities analyzed that this discrepancy stemmed from consolidated accounting effects resulting from exchange rate fluctuations.
Shin Min-soo, an analyst at KIWOOM Securities, explained, “In the consolidated financial statements, unrealized gains held by the headquarters and included in the inventory of overseas direct-sales subsidiaries are valued at the quarter-end exchange rate and subsequently eliminated.” He continued, “When the quarter-end exchange rate declines, the won-denominated amount of the unrealized gains subject to elimination decreases.” He added, “This is because cost of goods sold on the consolidated income statement decreases by the same amount.”
Simply put, as the exchange rate applied to overseas subsidiaries’ inventory declined, consolidated cost of goods sold decreased, independent of any actual increase in sales. Therefore, excluding this temporary accounting effect caused by exchange rate fluctuations, third-quarter ordinary operating profit is estimated at 13.9 billion won. This represents a 6.1% decrease from the second-quarter operating profit of 14.8 billion won, which excludes a one-time tariff refund of 2.9 billion won. While reported operating profit increased by 8.9% compared to the previous quarter, profit excluding one-time factors actually decreased.
InBody Co., Ltd. also noted, “Applying an ordinary operating profit margin of approximately 19.5% to third-quarter revenue of 71.3 billion won yields an ordinary operating profit of about 13.9 billion won,” adding, “The second-quarter operating profit of 17.7 billion won included a one-time tariff refund of 2.9 billion won; excluding this, the second-quarter ordinary operating profit was 14.8 billion won.”
Nevertheless, the company was cautious about interpreting this as a sign of weak performance. An InBody official emphasized, “Even excluding one-time gains and the effects of exchange rate fluctuations, we are delivering results in line with market consensus,” adding, “Despite external variables, we are maintaining a performance trend that aligns seamlessly with the business plan established at the beginning of the year.”
Exchange Rate Boosted Operating Profit but Halved Net Profit
Exchange rates also played a role in the divergent trends between operating profit and net income. InBody Co., Ltd. reflected foreign currency translation losses of 9.8 billion won and foreign exchange losses of 1.3 billion won in its third-quarter financial expenses. Net financial income, calculated by subtracting financial expenses from financial income, recorded a deficit of 13.5 billion won. This was the primary reason why pre-tax profit amounted to only 5.3 billion won, despite operating profit reaching 19.3 billion won.
In response, the company explained, “These are not losses accompanied by cash outflows; they arose from the revaluation of foreign currency-denominated accounts receivable at the exchange rate prevailing at the end of the quarter.” In other words, the strengthening of the won reduced the won-denominated value of dollar-denominated accounts receivable, resulting in an accounting valuation loss.
In contrast, the 1.3 billion won foreign exchange loss represents a loss incurred during actual foreign currency transactions. While the decline in third-quarter net income was largely driven by valuation losses that did not involve cash outflows, losses arising from actual transactions were also partially reflected.
Cash flow itself improved. Cumulative cash flow from operating activities for the first three quarters of this year totaled 28.5 billion won, a 29.3% increase from 22.1 billion won in the same period last year. In contrast to the sharp decline in net income, the company’s ability to generate cash through operating activities remained strong.
Overseas Growth, Domestic Slump… Profit Decline Expected in the Fourth Quarter
In terms of regional performance, there was a clear contrast between overseas and domestic markets. Third-quarter sales in North America rose 34% year-over-year, while domestic sales fell 15%. Cumulative U.S. revenue for the first three quarters of this year reached 77.3 billion won, up 35.4% year-over-year, while European revenue rose 30.7% to 27.4 billion won. During the same period, domestic revenue fell 11.2% from 29.9 billion won to 26.6 billion won.
InBody Co., Ltd. claimed that its growth in North America is also linked to the expansion of the GLP-1-based obesity treatment market. According to data from its U.S. subsidiary, as of June of this year, the GLP-1-related revenue category in North America had increased by 30% year-over-year. However, the company did not disclose the specific scale of this revenue, the number of units sold, or the contribution of high-end products to sales.
Sales growth for InBody Co., Ltd.’s home-use products slowed significantly in just one quarter. The year-over-year sales growth rate fell by 33.9 percentage points, from 48.1% in the second quarter to 14.2% in the third quarter. In contrast, the average export price for home-use products rose from $234 (approximately 330,000 won) annually last year to $276 (approximately 400,000 won) for the first three quarters of this year. Cumulative export revenue through September of this year also reached 21 billion won, already surpassing last year’s annual export revenue of 18.6 billion won.
Concerns have been raised that rising marketing costs could put pressure on profitability. InBody Co., Ltd.’s third-quarter advertising and promotional expenses totaled 4.8 billion won, a 54.7% increase year-over-year, significantly outpacing the revenue growth rate. This raises concerns that profitability could be eroded by the expansion of overseas sales networks and rising marketing costs.
The securities industry’s outlook for InBody Co., Ltd.’s fourth-quarter profitability is also not particularly bright. KIWOOM Securities and MIRAE ASSET SECURITIES forecast fourth-quarter operating profit at 11.7 billion won and 14.3 billion won, respectively. These figures represent decreases of 39% and 26%, respectively, compared to the third quarter. Analyst Shin stated, “There will be no tariff refunds in the fourth quarter, and the impact of exchange rates will also be less significant than in the third quarter,” adding, “Taking into account seasonal cost factors such as year-end performance bonuses, we expect the operating profit margin to be 15.8%.”
InBody Co., Ltd.(041830)reported that its operating profit for the third quarter of this year nearly doubled year-over-year; however, its recurring operating profit—excluding one-time accounting effec…
GS Retail(007070)has supported domestic small and medium-sized partner companies in Vietnam in expanding their overseas sales channels, resulting in export consultation deals totaling approximately $1…
Boil-like lumps repeatedly form and burst in areas such as the armpits and groin. Pus, oozing, and pain persist, and if the condition worsens, drainage tracts (channels connecting lesions beneath the …